News

The CEO of Transcarent sat down with MobiHealthNews outside the JPM Healthcare Conference to discuss AI's place in healthcare and its use in expanding access.

Seoul National University Hospital researchers have developed an AI model that predicts the response to an anticonvulsant drug.

Panelists at an event outside the JPM Healthcare conference discussed how AI is essential to addressing gaps in healthcare access and delivery.

The partnership combines Abridge's conversational AI platform with Availity’'s FHIR-native Intelligent Utilization Management technology.

Julia Zarb, principal and founder of Blue x Blue, discusses her upcoming HIMSS26 talk, exploring 'human in the loop' AI practices and workflows that support human decision-making.

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers of transplant rejection and patient response variability.

Private rheumatologist Dr Anandita Santosa in Singapore notes how current AI in healthcare priorities practically leave autoimmune and rheumatic diseases behind and shares what can be done to build a more comprehensive AI-driven preventive care ecosystem.

Clinician innovators across the region see the next phase of healthcare AI focusing on trust and responsible adoption after a year of rapid experimentation.

Predictions from Australia to Southeast Asia highlight where AI, telehealth, and platform consolidation are headed next.

The announcement comes less than a week after OpenAI announced the release of ChatGPT Health.